Reply to Anderson and Caniza.
Reply to Anderson and Caniza.
复制标题
回复安德森和卡尼萨。
DOI:
10.1093/cid/ciaa1628
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Kelly,MatthewS
中科院分区:
文献类型:
--
作者:
Congdon,Morgan;Arscott-Mills,Tonya;Kelly,MatthewS
To the Editor—We thank Anderson and Caniza for their letter and interest in our article on the impact of Haemophilus influenzae type b and 13-valent pneumococcal conjugate vaccines on child pneumonia hospitalizations and deaths in Botswana [1]. They highlight the continued high pneumonia mortality among children of mothers with human immunodeficiency virus (HIV) in our study despite introduction of these vaccines. The authors also express concern about the effect of the coronavirus disease 2019 (COVID-19) pandemic on immunization and other child health programs, noting that disruptions of these services may be particularly detrimental to the health of children of mothers with HIV. As pediatricians working to improve the health of children in Botswana and other low-and middle-income countries (LMICs), we share these concerns and agree that concerted action is necessary to prevent a reversal of the recent health gains experienced in these countries. Both children with HIV and HIV-exposed, uninfected (HEU) children have higher infectious morbidity and mortality than the children of mothers without HIV (unexposed)[2]. In particular, prior studies suggest that much of this excess mortality results from pneumonia [3–6]. Although a number of factors contribute to their high infection risk, children with HIV and HEU children acquire lower levels of maternal antibodies to several common childhood pathogens, including H. influenzae type B and Streptococcus pneumonia [7, 8]. However, children with HIV and HEU children generate robust antibody responses to these pathogens following routine vaccination, illustrating the importance of prioritizing these vulnerable groups for vaccination services in Botswana and other settings with high HIV prevalence. The COVID-19 pandemic has a substantial impact on the World Health Organization (WHO), the United Nations Children’s Fund, and the Global Alliance for Vaccines and Immunizations estimate that routine immunization services could be disrupted for more than 80 million children aged< 1 year during the pandemic [9]. In many LMICs, chronic underfunding of child health programs has been exacerbated as staff and resources have been reallocated to COVID-19 preparedness and response efforts [9–11]. Closures of country borders have interrupted vaccine supply chains, and personal protective equipment shortages have hindered the ability to offer routine vaccination services [11]. In Botswana, public clinics instituted additional safety precautions and provided vaccines and other essential child health